Please login to the form below

Not currently logged in
Email:
Password:

Neurodegenerative disease

This page shows the latest Neurodegenerative disease news and features for those working in and with pharma, biotech and healthcare.

EU approves bluebird bio’s CALD gene therapy Skysona

EU approves bluebird bio’s CALD gene therapy Skysona

CALD is a progressive and fatal neurodegenerative disease that overwhelmingly affects males. ... The European Commission (EC) has approved bluebird bio’s gene therapy Skysona for the rare inherited neurological disease cerebral adrenoleukodystrophy

Latest news

More from news
Approximately 3 fully matching, plus 73 partially matching documents found.

Latest Intelligence

  • AI and accelerated computing ring in new era for healthcare AI and accelerated computing ring in new era for healthcare

    A disease pathway – a chain of signals between molecules that trigger different cell functions – may involve thousands of interacting proteins. ... The project is initially connecting four of London’s premier teaching hospitals, offering AI

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimer’s ahead of a cure

    Yet the effort to find different ways to combat the neurodegenerative disease have not stalled, with researchers looking into the possibility of early detection as a new avenue to explore in ... According to the study, the blood test is able to identify

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    Nevertheless, strategies for developing successful therapeutic interventions are shifting. We have developed a five-point roadmap to successful treatments for Alzheimer’s disease and neurodegenerative diseases. ... Hyper-stimulation of microglial cells

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    The design of such neuroprotective studies may benefit from the lessons learned in studies in the most common neurodegenerative disease, Alzheimer’s. ... Target early disease stages: It is probably true for all neurodegenerative diseases that symptoms

  • Pharma deals during January 2013 Pharma deals during January 2013

    During the option, AZ will continue to research and evaluate OX CLI in respiratory disease (see table 2). ... SMA is an orphan neurodegenerative genetic disease that presents early in life.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • New hires at EMA, Gilead and BeiGene New hires at EMA, Gilead and BeiGene

    Most recently, Grant was chief executive officer of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease.

  • Prevail Therapeutics adds to its board of directors Prevail Therapeutics adds to its board of directors

    Francois Nader joins the biotech. Prevail Therapeutics, a biotechnology company focused on the development of gene therapies for patients with neurodegenerative diseases, has strengthened its board of directors with the addition ... The Prevail team has

  • Asceneuron appoints chief medical officer Asceneuron appoints chief medical officer

    Novartis’ Michael Ryan joins the neurodegenerative diseases specialist. Lausanne, Switzerland-based Asceneuron has appointed Michael Ryan as its new chief medical officer. ... His outstanding track record and expertise in neurodegenerative disease are

  • Eisai recruits Pfizer and Sanofi execs to neurology group Eisai recruits Pfizer and Sanofi execs to neurology group

    As global lead for Alzheimer's Disease she will also be tasked with developing strategies and heading internal and external collaborations. . ... Eisai's Cheung said: "With her deep expertise in the commercial development of in-line and

  • Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals

    The US-based pharmaceutical firm specialises in developing disease-modifying treatments for neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS). ... Loeb University Professor Emeritus at Harvard University. He said: “Amylyx has

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Impetus Digital Fireside Chat With Richie Bavasso From NqMedical

    Richie Bavasso, founder and CEO of  nQMedical,  discusses everything from digital therapeutics, diagnostics, and other data-driven solutions for neurodegenerative diseases to Richie’s favorite media outlets, his work at nQMedical,

  • The ALS patient journey

    Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). ... ALS is a progressive neurodegenerative disease, and the fast onset of increasingly severe symptoms after diagnosis can be devastating.

  • Why eating people is wrong (and other medical discoveries)

    The case against cannibalism began with an earlier medical discovery. A neurodegenerative disease known as kuru was found to be common among the Fore people of Papua New Guinea. ... This was later identified as a prion (misfolded protein), and therefore

  • Conference Live: Case study

    The challenge:. Our client was developing a portfolio for the treatment of a chronic neurodegenerative disease and planned to have a significant presence at key neuroscience conferences over the coming year.

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...